🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Citibank

9 posts
Read More

Supernus and Indivior complete merger, creating $2.2bn CNS pharma group

Supernus Pharmaceuticals and Indivior Pharmaceuticals have completed their merger, establishing a diversified central nervous system drug company with approximately $2.2 billion in historical pro forma annual revenue. The transaction combines five core growth medicines and targets $125 million in annual cost savings, but a $1 billion special dividend and new debt obligations place financial discipline alongside commercial expansion.
Read More

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Affle 3i has agreed to acquire Israeli advertising technology company Perion for approximately $420 million, offering shareholders a 34.5% premium and a 40-day opportunity to attract competing bids. The target's $228.3 million cash and investment balance, Affle's financing plans and differences between their advertising business models make the transaction more complex than its headline valuation suggests.
Infographic highlighting Guidewire’s agreement to acquire hyperexponential for $1.7 billion in cash plus up to $400 million tied to recurring revenue targets, alongside AI-assisted insurance underwriting opportunities and financing and integration challenges.
Read More

Guidewire (GWRE) to acquire hyperexponential for up to $2.1bn as AI underwriting strategy accelerates

Guidewire has agreed to acquire London-based hyperexponential for $1.7 billion in cash plus up to $400 million tied to recurring revenue targets. The insurance software group expects the transaction to accelerate annual recurring revenue growth and deepen its position in AI-assisted commercial underwriting, while introducing substantial financing and integration requirements.
Read More

Nebius (NASDAQ: NBIS) has $40bn in AI contracts. Why borrow $3.5bn for one year?

Nebius Group has secured a US$3.5 billion financing facility to accelerate its artificial intelligence infrastructure expansion, despite having more than US$40 billion in long-term customer commitments. The one-year maturity, floating interest rate and secured borrowing structure raise an important question about how the company plans to finance its next phase of growth.